A cost-effective method for the clinical diagnosis of AD was introduced based on the electrochemical detection of clusterin in spiked plasma using a screen-printed carbon electrode modified with 1-pyrenebutyric acid N-hydroxysuccinimide ester and decorated with specific anti-clusterin antibody fragments [36]. This evidence concerns the gene CLU and Alzheimer disease.